A new study has found that consuming sugary foods and drinks like smoothies can increase the gastrointestinal side effects ...

Thoracic oncologist Kathryn Arbour, MD, led the Phase 1/2 clinical trial of daraxonrasib at MSK for metastatic lung cancer. The drug was approved by the FDA for pancreatic cancer in August 2026 and Dr ...

Key Takeaways The FDA has approved zanidatamab (Ziihera®) as a first treatment for patients newly diagnosed with HER2-positive advanced cancers of the esophagus, gastroesophageal junction, and stomach ...

MSK researchers have identified genomic changes in recurrent gastric tumors that could improve personalized care and post-operative monitoring of this deadly type of cancer. In the study, researchers ...

Contact information If you have questions, call MSK’s Fine Needle Aspiration Biopsy Clinic. You can reach them Monday through Friday, between 8:30 a.m. and 5:30 p.m. at 212-639-5990. If you’re a ...